← Back to Search

4-session intervention for Borderline Personality Disorder

N/A
Waitlist Available
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3 and 6 month follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to reduce health care utiliz. for ppl with BPD (borderline personality disorder) who present with suicidal ideation or self-harm in emergency depts. A 4-session psychotherapeutic intervention is being tested & may provide promising results.

Eligible Conditions
  • Borderline Personality Disorder
  • Suicide and Self-Harm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3 and 6 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3 and 6 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary clinical outcome measure - Emergency Department Visits

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 4-session interventionExperimental Treatment2 Interventions
Group II: Treatment as usualActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment as usual
2010
N/A
~6970

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
368 Previous Clinical Trials
82,976 Total Patients Enrolled
5 Trials studying Borderline Personality Disorder
835 Patients Enrolled for Borderline Personality Disorder
~15 spots leftby Nov 2025